TRIOMA®

Solution for injection, 2.5mg/ml
RxActive license

Active substance (INN)

bortezomib

Pharmaceutical form

Pharmaceutical formSolution for injection
Strength2.5mg/ml
PackagingUkupno 1 bočica staklena sa 1.4ml rastvora za injekciju u kartonskoj kutiji
ManufacturerStada Arzneimittel AG, Germany
Therapeutic groupAntineoplastic and immunomodulating agents (L01XG01)
Marketing authorization holderHEMOFARM A.D. VRŠAC P.J. PODGORICA
Authorization dateJuly 31, 2023

Analogs in Montenegro

4

Other medicines with the same active substance

BORTEGAZRx
Powder for solution for injection, 3.5mgOncotec Pharma Produktion GmbH
BORTEZOMIB PLIVARx
Powder for solution for injection, 3.5mgS. C. Sindan-Pharma S.r.l.
GLOFTRINIDRestricted
Powder for solution for injection, 3.5mgAlkaloid AD Skopje
VORTEMYELRx
Powder for solution for injection, 3.5mgSynthon Hispania S.L.
Source: CInMED register